3. Kim HJ, Kim MH, Park SJ, et al. Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea. J Allergy Clin Immunol 2024;153:1711-20.
4. Dunn J, Henrikson NB, Morrison CC, et al. Screening for adolescent idiopathic scoliosis: evidence report and systematic review for the US Preventive Services Task Force. JAMA 2018;319:173-87.
6. Lee Y, Kirubarajan A, Patro N, et al. Impact of hospital lockdown secondary to COVID-19 and past pandemics on surgical practice: a living rapid systematic review. Am J Surg 2021;222:67-85.
7. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344-9.
9. Cho NI, Hwang CJ, Kim HY, et al. Referral patterns and patient characteristics at the first visit to a scoliosis center: a 2-year experience in South Korea without a school scoliosisscreening program. J Neurosurg Pediatr 2018;21:414-20.
14. Prosperi S, Chiarelli F. Early and precocious puberty during the COVID-19 pandemic. Front Endocrinol (Lausanne) 2022;13:1107911.
15. Fong DY, Cheung KM, Wong YW, et al. A population-based cohort study of 394,401 children followed for 10 years exhibits sustained effectiveness of scoliosis screening. Spine J 2015;15:825-33.
16. Bond DM, Seimon R, Schneuer FJ, et al. Impact and recovery of the COVID-19 pandemic on weight status of children and adolescents. Clin Obes 2023;13:e12579.
20. Kim S, Uhm JY, Chae DH, et al. Low body mass index for early screening of adolescent idiopathic scoliosis: a comparison based on standardized body mass index classifications. Asian Nurs Res (Korean Soc Nurs Sci) 2020;14:24-9.
28. Grossman DC, Curry SJ, Owens DK, et al. Screening for adolescent idiopathic scoliosis: US Preventive Services Task Force recommendation statement. JAMA 2018;319:165-72.